ID

32338

Descrizione

Study ID: 109563 Clinical Study ID: 109563 Study Title: COMPAS:A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier https://clinicaltrials.gov/ct2/show/NCT00466947 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) Trade Name: BIO 10PN-PD-DIT; Synflorix Study Indication: Infections, Streptococcal The Study consists of three workbooks. Workbook 1: Argentina, all subjects + immuno & reacto subset Workbook 2: Panama, all subjects + immuno & reacto subset + carriage subset + additional immuno subset Workbook 3: Colombia, all subjects The protocol number for all workbooks: 109563 (10Pn-PD-DiT-028) There are ten visits in workbook 1 and 2, eight for workbook 3 (there are no visits 4 and 7): Visit 1: month 0, dose 1, 6-16 weeks of age Visit 2: month 2, dose 2, +/- 4 months of age, 49-83 days after visit 1 Visit 3: month 4, dose 3, +/- 6 months of age, 49-83 days after visit 2 Visit 4: month 5, +/- 7 months of age, 28-42 days after visit 3. Only for immuno & reacto subset + carriage subset. Visit 5: month 10-13, 12-15 months of age Visit 6: month 13-16, booster dose, 15-18 months of age, ≥ 28 days after visit 5 Visit 7: month 14-17, 16-19 months of age, 28-42 days after visit 6. Only for immuno & reacto subset, additional immuno subset + carriage subset. Visit 8: month 16-19, 18-21 months of age, ≥ 28 days after visit 6 Visit 9: month 22-25, 24-27 months of age Visit 10: Contact This document contains the study conclusion form. It's for all workbooks.

collegamento

https://clinicaltrials.gov/ct2/show/NCT00466947

Keywords

versioni (2)
  1. 26/10/18 26/10/18 -
  2. 27/10/18 27/10/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

27 ottobre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Vaccination against pneumonia and otitis media, NCT00466947

Inglese

Study conclusion

1 moduli  
  1. StudyEvent: ODM
    1. Study conclusion
Administrative data
Descrizione

Administrative data

Alias
UMLS CUI-1
C1320722
Subject number
Descrizione

Subject number

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Workbook number
Descrizione

Workbook number

Tipo di dati

integer

Alias
UMLS CUI [1]
C2986015
Date of study conclusion
Descrizione

Date of study conclusion

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1707478
UMLS CUI [1,2]
C0008972
UMLS CUI [1,3]
C0011008
STUDY CONCLUSION: OCCURRENCE OF SERIOUS ADVERSE EVENT
Descrizione

STUDY CONCLUSION: OCCURRENCE OF SERIOUS ADVERSE EVENT

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
UMLS CUI-3
C1519255
Did the subject experience any Serious Adverse Event during the study?
Descrizione

Serious Adverse Event during study

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0008972
If Serious Adverse Event during the study occured, please specify total number of SAE's
Descrizione

Total number of SAE's

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C1519255
STATUS OF TREATMENT BLIND
Descrizione

STATUS OF TREATMENT BLIND

Alias
UMLS CUI-1
C0749659
UMLS CUI-2
C2347038
Was the subject unblinding event record during the study?
Descrizione

Complete Serious Adverse Event report as appropriate. For workbook 2 you can also complete Non-Serious Adverse Event section as appropriate.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C2347038
If subject unblinding event record, complete the date
Descrizione

Subject unblinding event record, date

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C3897431
UMLS CUI [1,3]
C2347038
Subject unblinding event record, reason
Descrizione

Subject unblinding event record, reason

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C2347038
UMLS CUI [1,3]
C0566251
If other reason for subject unblinding event record, please specify
Descrizione

Other reason for subject unblinding event record

Tipo di dati

text

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C2347038
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C0566251
ELIMINATION CRITERIA
Descrizione

ELIMINATION CRITERIA

Alias
UMLS CUI-1
C0680251
Did any elimination criteria become applicable since last visit?
Descrizione

Please tick all that applies in following items.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1706839
Chronic administration of immunosuppressants or other immune-modifying drugs.
Descrizione

Chronic administration is defined as more than 14 days

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0021081
UMLS CUI [1,3]
C0205191
UMLS CUI [1,4]
C0005525
Major congenital defects or serious chronic illness.
Descrizione

Elimination criteria: Major congenital defects/serious chronic illness.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0220810
UMLS CUI [2,2]
C0205164
UMLS CUI [3,1]
C0008679
UMLS CUI [3,2]
C0205404
Any confirmed or suspected immunosuppressive or immunodeficient condition.
Descrizione

Elimination criteria: confirmed/suspected immunosuppressive/immunodeficient condition.

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0750484
UMLS CUI [2,2]
C3829792
UMLS CUI [3,1]
C0750484
UMLS CUI [3,2]
C4048329
UMLS CUI [4,1]
C0242114
UMLS CUI [4,2]
C3829792
UMLS CUI [5,1]
C0242114
UMLS CUI [5,2]
C4048329
Administration of immunoglobulins and/or any blood derived products.
Descrizione

Elimination criteria: immunoglobulins/any blood derived products

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0021027
UMLS CUI [3]
C0456388
Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s).
Descrizione

Elimination criteria: use of investigational or non-registered product

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0304229
UMLS CUI [2,2]
C0042210
UMLS CUI [2,3]
C1444655
UMLS CUI [2,4]
C2348563
Withdrawing from study
Descrizione

Withdrawing from study

Alias
UMLS CUI-1
C0422727
Was the subject withdrawn from the study?
Descrizione

If yes, note major reason. Therefore tick one of the following items

Tipo di dati

text

Alias
UMLS CUI [1]
C0422727
Reason for withdrawal
Descrizione

If you tick SAE, please complete and submit SAE report. If you tick AEX, please complete Non-serious Adverse Event section.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0008976
If SAE, please specify SAE Number
Descrizione

Please complete and submit SAE report

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0237753
If AEX, please specify AE Number
Descrizione

Please complete Non-serious Adverse Event section

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0237753
If AEX, please specify solicited AE Code
Descrizione

In workbook 1 and 2 only for immuno and reato subset.

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0683368
UMLS CUI [1,2]
C1517001
UMLS CUI [1,3]
C1518404
UMLS CUI [1,4]
C0805701
If protocol violation, please specify
Descrizione

Protocol violation

Tipo di dati

text

Alias
UMLS CUI [1]
C1709750
If other reason for withdrawal, please specify
Descrizione

Withdrawal, other reason

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C3840932
Who made the decision
Descrizione

Dicision made by

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0679006
UMLS CUI [1,2]
C2349954
UMLS CUI [1,3]
C0682237
Date of last contact
Descrizione

Date of last contact

Tipo di dati

date

Alias
UMLS CUI [1]
C0805839
Was the subject in good condition at date of last contact
Descrizione

If you tick No, please give details in Adverse Events section.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0805839
UMLS CUI [1,2]
C1142435
INVESTIGATOR'S SIGNATURE
Descrizione

INVESTIGATOR'S SIGNATURE

Alias
UMLS CUI-1
C2346576
Investigator's signature
Descrizione

Investigator's signature

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Date of signature
Descrizione

Date of signature

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Printed Investigator's name
Descrizione

Printed Investigator's name

Tipo di dati

text

Alias
UMLS CUI [1]
C2826892
Ritorna all'inizio della pagina

Similar models

Study conclusion

1 moduli
  1. StudyEvent: ODM
    1. Study conclusion
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item
Workbook number
integer
C2986015 (UMLS CUI [1])
Workbook number
Code List
Workbook number
CL Item
workbook 1 (1)
CL Item
workbook 2 (2)
CL Item
workbook 3 (3)
Date of study conclusion
Item
Date of study conclusion
date
C1707478 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item Group
STUDY CONCLUSION: OCCURRENCE OF SERIOUS ADVERSE EVENT
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
Item
Did the subject experience any Serious Adverse Event during the study?
text
C1519255 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Serious Adverse Event during study
Code List
Did the subject experience any Serious Adverse Event during the study?
CL Item
No (N)
CL Item
Yes (Y)
Total number of SAE's
Item
If Serious Adverse Event during the study occured, please specify total number of SAE's
integer
C0449788 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item Group
STATUS OF TREATMENT BLIND
C0749659 (UMLS CUI-1)
C2347038 (UMLS CUI-2)
Item
Was the subject unblinding event record during the study?
text
C3897431 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
Treatment blind broken
Code List
Was the subject unblinding event record during the study?
CL Item
No  (N)
CL Item
Yes (Y)
Subject unblinding event record, date
Item
If subject unblinding event record, complete the date
date
C0011008 (UMLS CUI [1,1])
C3897431 (UMLS CUI [1,2])
C2347038 (UMLS CUI [1,3])
Item
Subject unblinding event record, reason
integer
C3897431 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Treatment blind broken, reason
Code List
Subject unblinding event record, reason
CL Item
Medical emergency requiring identification of investigational product for further treatments (1)
CL Item
Other (9)
Other reason for subject unblinding event record
Item
If other reason for subject unblinding event record, please specify
text
C3897431 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
Item Group
ELIMINATION CRITERIA
C0680251 (UMLS CUI-1)
Item
Did any elimination criteria become applicable since last visit?
text
C0680251 (UMLS CUI [1,1])
C1706839 (UMLS CUI [1,2])
Elimination criteria become applicable
Code List
Did any elimination criteria become applicable since last visit?
CL Item
No (N)
CL Item
Yes (Y)
Elimination criteria: immunosuppressants/immune-modifying drugs
Item
Chronic administration of immunosuppressants or other immune-modifying drugs.
boolean
C0680251 (UMLS CUI [1,1])
C0021081 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0005525 (UMLS CUI [1,4])
Elimination criteria: Major congenital defects/serious chronic illness.
Item
Major congenital defects or serious chronic illness.
boolean
C0680251 (UMLS CUI [1])
C0220810 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C0008679 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
Elimination criteria: confirmed/suspected immunosuppressive/immunodeficient condition.
Item
Any confirmed or suspected immunosuppressive or immunodeficient condition.
boolean
C0680251 (UMLS CUI [1])
C0750484 (UMLS CUI [2,1])
C3829792 (UMLS CUI [2,2])
C0750484 (UMLS CUI [3,1])
C4048329 (UMLS CUI [3,2])
C0242114 (UMLS CUI [4,1])
C3829792 (UMLS CUI [4,2])
C0242114 (UMLS CUI [5,1])
C4048329 (UMLS CUI [5,2])
Elimination criteria: immunoglobulins/any blood derived products
Item
Administration of immunoglobulins and/or any blood derived products.
boolean
C0680251 (UMLS CUI [1])
C0021027 (UMLS CUI [2])
C0456388 (UMLS CUI [3])
Elimination criteria: use of investigational or non-registered product
Item
Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s).
boolean
C0680251 (UMLS CUI [1])
C0304229 (UMLS CUI [2,1])
C0042210 (UMLS CUI [2,2])
C1444655 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,4])
Item Group
Withdrawing from study
C0422727 (UMLS CUI-1)
Item
Was the subject withdrawn from the study?
text
C0422727 (UMLS CUI [1])
Withdrawal from study
Code List
Was the subject withdrawn from the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Reason for withdrawal
text
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Reason for withdrawal
Code List
Reason for withdrawal
CL Item
Serious adverse event (SAE)
CL Item
Non-Serious adverse event (AEX)
CL Item
Protocol violation (PTV)
CL Item
Consent withdrawal, not due to an adverse event (CWS)
CL Item
Migrated / moved from the study area (MIG)
CL Item
Lost to follow-up (LFU)
CL Item
Other (OTH)
SAE Number
Item
If SAE, please specify SAE Number
integer
C1519255 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
AE Number
Item
If AEX, please specify AE Number
integer
C1518404 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Solicited AE Code
Item
If AEX, please specify solicited AE Code
integer
C0683368 (UMLS CUI [1,1])
C1517001 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,3])
C0805701 (UMLS CUI [1,4])
Protocol violation
Item
If protocol violation, please specify
text
C1709750 (UMLS CUI [1])
Withdrawal, other reason
Item
If other reason for withdrawal, please specify
text
C2349954 (UMLS CUI [1,1])
C3840932 (UMLS CUI [1,2])
Item
Who made the decision
text
C0679006 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0682237 (UMLS CUI [1,3])
Dicision made by
Code List
Who made the decision
CL Item
Investigator  (I)
CL Item
Parents/Guardians (P)
Date of last contact
Item
Date of last contact
date
C0805839 (UMLS CUI [1])
Item
Was the subject in good condition at date of last contact
text
C0805839 (UMLS CUI [1,1])
C1142435 (UMLS CUI [1,2])
Condition at date of last contact
Code List
Was the subject in good condition at date of last contact
CL Item
No (N)
CL Item
Yes (Y)
Item Group
INVESTIGATOR'S SIGNATURE
C2346576 (UMLS CUI-1)
Investigator's signature
Item
Investigator's signature
text
C2346576 (UMLS CUI [1])
Date of signature
Item
Date of signature
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Printed Investigator's name
Item
Printed Investigator's name
text
C2826892 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial